CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients Expansion or contraction of stenting in coronary artery disease? Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial Ticagrelor versus clopidogrel in patients with acute coronary syndromes

JOURNAL:CBS2017 Article Link

CBS exhibits at EuroPCR 2017 in Paris

CBS2017

Paris, France - Starting from May 16, Left Main & Coronary Bifurcation Summit (CBS) will present the next congress plan at EuroPCR 2017 in Paris. An on-site platform for treatment against left main and coronary bifurcation lesions will be located on the third floor of the Palais des Congrès. All participants and cardiovascular experts are welcomed to CBS booth stand H9 during this 4-day meeting.

On the 10th Summit in this winter, CBS will continue the concept of patient-centric care. Discussion on the objectives like applying big data with well designed RCT to obtain more clinical evidence, incorporation of new interventional technologies and treatment options, integration of hemodynamic evaluation and mechanisms into the treatment, analysis and comparison of treatment options will be put on extra weight. CBS2017 will be helpful to make a comprehensive and in-depth academic exploration on the issue of left main and coronary bifurcation disease.